VTAK
Catheter Precision Inc.
NYSE MKT: VTAK · HEALTHCARE · MEDICAL DEVICES
$0.94
+0.77% today
Updated 2026-04-29
Market cap
$2.51M
P/E ratio
—
P/S ratio
3.07x
EPS (TTM)
$-15.90
Dividend yield
—
52W range
$1 – $16
Volume
1.4M
WallStSmart proprietary scores
38
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A4.0
Quality
C2.5
Profitability
F4.0
Valuation
C4/9
Piotroski F-Score
Moderate
-16.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$2.00
+112.77%
12-Month target
$2.02
+114.89%
Intrinsic (DCF)
$1.30
Margin of safety
-46.15%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 59.70% QoQ
Risks
- Altman Z -16.50 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.59M
- 46.15% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $14000.00 | $442000.00 | $420000.00 | $819000.00 | $819000.00 |
| Net income | $-26.86M | $-70.57M | $-16.64M | $-17.18M | $-5.34M |
| EPS | — | — | — | — | $-15.90 |
| Free cash flow | $-22.59M | $-20.70M | $-9.34M | $-8.31M | $-1.59M |
| Profit margin | -191,892.86% | -15,966.52% | -3,962.62% | -2,098.05% | — |
Peer comparison
Smart narrative
Catheter Precision Inc. trades at $0.94. Our Smart Value Score of 38/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -16.50, it sits in the distress. TTM revenue stands at $819000.00. Our DCF model estimates intrinsic value at $1.30.
Frequently asked questions
What is Catheter Precision Inc.'s stock price?
Catheter Precision Inc. (VTAK) trades at $0.94.
Is Catheter Precision Inc. overvalued?
Smart Value Score 38/100 (Grade D, Sell). DCF value $1.30.
What is the price target of Catheter Precision Inc. (VTAK)?
The analyst target price is $2.00, representing +112.8% upside from the current price of $0.94.
What is the intrinsic value of Catheter Precision Inc. (VTAK)?
Based on our DCF model, intrinsic value is $1.30, a -46.1% margin of safety versus $0.94.
What is Catheter Precision Inc.'s revenue?
TTM revenue is $819000.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-16.50 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio3.07x
ROE-192.30%
Beta0.26
50D MA$1.25
200D MA$2.22
Shares out0.00B
Float0.00B
Short ratio—
Avg volume1.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—